SlideShare une entreprise Scribd logo
1  sur  4
Aarkstore.com announces, The Latest market research report is available in
its vast collection:

B-Cell Non-Hodgkin Lymphoma – Pipeline Review, H2 2012




You can also request for sample page of above mention reports on
sample@aarkstore.com



Summary

Global Markets Direct’s, B-Cell Non-Hodgkin Lymphoma - Pipeline Review, Global
Markets Direct’s, B-Cell Non-Hodgkin Lymphoma - Pipeline Review, H2 2012,
provides an overview of the indication’s therapeutic pipeline. This report provides
information on the therapeutic development for B-Cell Non-Hodgkin Lymphoma,
complete with latest updates, and special features on late-stage and discontinued
projects. It also reviews key players involved in the therapeutic development for B-
Cell Non-Hodgkin Lymphoma. B-Cell Non-Hodgkin Lymphoma - Pipeline Review,
Half Year is built using data and information sourced from Global Markets Direct’s
proprietary databases, Company/University websites, SEC filings, investor
presentations and featured press releases from company/university sites and
industry-specific third party sources, put together by Global Markets Direct’s team.

Note*: Certain sections in the report may be removed or altered based on the
availability and relevance of data for the indicated disease.

Scope

- A snapshot of the global therapeutic scenario for B-Cell Non-Hodgkin Lymphoma.
- A review of the B-Cell Non-Hodgkin Lymphoma products under development by
companies and universities/research institutes based on information derived from
company and industry-specific sources.
- Coverage of products based on various stages of development ranging from
discovery till registration stages.

Reasons to buy

- Identify and understand important and diverse types of therapeutics under
development for B-Cell Non-Hodgkin Lymphoma.
- Identify emerging players with potentially strong product portfolio and design
effective counter-strategies to gain competitive advantage.

Table of contents:

List of Tables 6
List of Figures 7
Introduction 8
Global Markets Direct Report Coverage 8
B-Cell Non-Hodgkin Lymphoma Overview 9
Therapeutics Development 10
An Overview of Pipeline Products for B-Cell Non-Hodgkin Lymphoma 10
B-Cell Non-Hodgkin Lymphoma Therapeutics under Development by Companies 12
B-Cell Non-Hodgkin Lymphoma Therapeutics under Investigation by
Universities/Institutes 15
Late Stage Products 18
Comparative Analysis 18
Mid Clinical Stage Products 19
Comparative Analysis 19
Early Clinical Stage Products 20
Comparative Analysis 20
Discovery and Pre-Clinical Stage Products 21
Comparative Analysis 21
B-Cell Non-Hodgkin Lymphoma Therapeutics – Products under Development by
Companies 22
B-Cell Non-Hodgkin Lymphoma Therapeutics – Products under Investigation by
Universities/Institutes 24
Companies Involved in B-Cell Non-Hodgkin Lymphoma Therapeutics Development
28
Bristol-Myers Squibb Company 28
Johnson & Johnson 29
Kyowa Hakko Kirin Co., Ltd. 30
Sanofi-Aventis 31
Genentech, Inc. 32
MedImmune LLC 33
Gilead Sciences, Inc. 34




List of Figures

List of Tables are also include.




For more related Reports Plz follow The link:



Pipeline Review, H2 2012
http://www.aarkstore.com/search/viewresults.asp?search=Pipeline Review, H2
2012&PubId=&pagenum=1



 Liver Cancer – Pipeline Review, H2 2012

 Non-Small Cell Lung Cancer – Pipeline Review, H2 2012

 Asthma – Pipeline Review, H2 2012

 Multiple Sclerosis – Pipeline Review, H2 2012

 Gastrointestinal Tract Cancer – Pipeline Review, H2 2012

 Diabetes – Pipeline Review, H2 2012
Chronic Lymphocytic Leukemia (CLL) – Pipeline Review, H2 2012

 Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) – Pipeline Review,
H2 2012

 Graft Versus Host Disease (GVHD) – Pipeline Review, H2 2012

 Malaria – Pipeline Review, H2 2012

 Methicillin-Resistant Staphylococcus Aureus (MRSA) Infections – Pipeline Review,
H2 2012

 Dermatitis – Pipeline Review, H2 2012




Search More Reports Related to This Category :

Pharmaceuticals and Healthcare
http://www.aarkstore.com/search/viewresults.asp?search=Pharmaceuticals and
Healthcare&PubId=&pagenum=1




For More details Plz do contact :

Aarkstore Enterprise

Lavanya

Phone:08149852585

Email: enquiry@aarkstore.com

Contenu connexe

Plus de Rose088

Acute renal failure (arf) (acute kidney injury)
Acute renal failure (arf) (acute kidney injury)Acute renal failure (arf) (acute kidney injury)
Acute renal failure (arf) (acute kidney injury)Rose088
 
Downstream processing in biopharmaceuticals adoption
Downstream processing in biopharmaceuticals   adoptionDownstream processing in biopharmaceuticals   adoption
Downstream processing in biopharmaceuticals adoptionRose088
 
Amyloidosis – pipeline review, h2 2012
Amyloidosis – pipeline review, h2 2012Amyloidosis – pipeline review, h2 2012
Amyloidosis – pipeline review, h2 2012Rose088
 
Incyte corporation – product pipeline review – 2012
Incyte corporation – product pipeline review – 2012Incyte corporation – product pipeline review – 2012
Incyte corporation – product pipeline review – 2012Rose088
 
Chinese markets for industrial lubricants
Chinese markets for industrial lubricantsChinese markets for industrial lubricants
Chinese markets for industrial lubricantsRose088
 
Zydus cadila healthcare limited – product pipeline review – 2012
Zydus cadila healthcare limited – product pipeline review – 2012Zydus cadila healthcare limited – product pipeline review – 2012
Zydus cadila healthcare limited – product pipeline review – 2012Rose088
 
Ziopharm oncology, inc. – product pipeline review – 2012
Ziopharm oncology, inc. – product pipeline review – 2012Ziopharm oncology, inc. – product pipeline review – 2012
Ziopharm oncology, inc. – product pipeline review – 2012Rose088
 
Topo target a s – product pipeline review – 2012
Topo target a s – product pipeline review – 2012Topo target a s – product pipeline review – 2012
Topo target a s – product pipeline review – 2012Rose088
 
Ym bio sciences inc. – product pipeline review – 2012
Ym bio sciences inc. – product pipeline review – 2012Ym bio sciences inc. – product pipeline review – 2012
Ym bio sciences inc. – product pipeline review – 2012Rose088
 
Astrocytoma – pipeline review, h2 2012
Astrocytoma – pipeline review, h2 2012Astrocytoma – pipeline review, h2 2012
Astrocytoma – pipeline review, h2 2012Rose088
 
Ipsen inc. – product pipeline review – 2012
Ipsen inc. – product pipeline review – 2012Ipsen inc. – product pipeline review – 2012
Ipsen inc. – product pipeline review – 2012Rose088
 
Methyl gene inc – product pipeline review – 2012
Methyl gene inc – product pipeline review – 2012Methyl gene inc – product pipeline review – 2012
Methyl gene inc – product pipeline review – 2012Rose088
 
Mer lion pharmaceuticals pte ltd – product pipeline review – 2012
Mer lion pharmaceuticals pte ltd – product pipeline review – 2012Mer lion pharmaceuticals pte ltd – product pipeline review – 2012
Mer lion pharmaceuticals pte ltd – product pipeline review – 2012Rose088
 
Glenmark pharmaceuticals ltd. – product pipeline review – 2012
Glenmark pharmaceuticals ltd. – product pipeline review – 2012Glenmark pharmaceuticals ltd. – product pipeline review – 2012
Glenmark pharmaceuticals ltd. – product pipeline review – 2012Rose088
 
Geron corporation – product pipeline review – 2012
Geron corporation – product pipeline review – 2012Geron corporation – product pipeline review – 2012
Geron corporation – product pipeline review – 2012Rose088
 
Immuno gen, inc. – product pipeline review – 2012
Immuno gen, inc. – product pipeline review – 2012Immuno gen, inc. – product pipeline review – 2012
Immuno gen, inc. – product pipeline review – 2012Rose088
 
7 tm pharma as – product pipeline review – 2012
7 tm pharma as – product pipeline review – 20127 tm pharma as – product pipeline review – 2012
7 tm pharma as – product pipeline review – 2012Rose088
 
Emerging power markets in south east asia
Emerging power markets in south east asiaEmerging power markets in south east asia
Emerging power markets in south east asiaRose088
 
Cloud computing in pharmaceutical research
Cloud computing in pharmaceutical researchCloud computing in pharmaceutical research
Cloud computing in pharmaceutical researchRose088
 

Plus de Rose088 (20)

Acute renal failure (arf) (acute kidney injury)
Acute renal failure (arf) (acute kidney injury)Acute renal failure (arf) (acute kidney injury)
Acute renal failure (arf) (acute kidney injury)
 
Downstream processing in biopharmaceuticals adoption
Downstream processing in biopharmaceuticals   adoptionDownstream processing in biopharmaceuticals   adoption
Downstream processing in biopharmaceuticals adoption
 
Amyloidosis – pipeline review, h2 2012
Amyloidosis – pipeline review, h2 2012Amyloidosis – pipeline review, h2 2012
Amyloidosis – pipeline review, h2 2012
 
Incyte corporation – product pipeline review – 2012
Incyte corporation – product pipeline review – 2012Incyte corporation – product pipeline review – 2012
Incyte corporation – product pipeline review – 2012
 
Chinese markets for industrial lubricants
Chinese markets for industrial lubricantsChinese markets for industrial lubricants
Chinese markets for industrial lubricants
 
Mumbai
MumbaiMumbai
Mumbai
 
Zydus cadila healthcare limited – product pipeline review – 2012
Zydus cadila healthcare limited – product pipeline review – 2012Zydus cadila healthcare limited – product pipeline review – 2012
Zydus cadila healthcare limited – product pipeline review – 2012
 
Ziopharm oncology, inc. – product pipeline review – 2012
Ziopharm oncology, inc. – product pipeline review – 2012Ziopharm oncology, inc. – product pipeline review – 2012
Ziopharm oncology, inc. – product pipeline review – 2012
 
Topo target a s – product pipeline review – 2012
Topo target a s – product pipeline review – 2012Topo target a s – product pipeline review – 2012
Topo target a s – product pipeline review – 2012
 
Ym bio sciences inc. – product pipeline review – 2012
Ym bio sciences inc. – product pipeline review – 2012Ym bio sciences inc. – product pipeline review – 2012
Ym bio sciences inc. – product pipeline review – 2012
 
Astrocytoma – pipeline review, h2 2012
Astrocytoma – pipeline review, h2 2012Astrocytoma – pipeline review, h2 2012
Astrocytoma – pipeline review, h2 2012
 
Ipsen inc. – product pipeline review – 2012
Ipsen inc. – product pipeline review – 2012Ipsen inc. – product pipeline review – 2012
Ipsen inc. – product pipeline review – 2012
 
Methyl gene inc – product pipeline review – 2012
Methyl gene inc – product pipeline review – 2012Methyl gene inc – product pipeline review – 2012
Methyl gene inc – product pipeline review – 2012
 
Mer lion pharmaceuticals pte ltd – product pipeline review – 2012
Mer lion pharmaceuticals pte ltd – product pipeline review – 2012Mer lion pharmaceuticals pte ltd – product pipeline review – 2012
Mer lion pharmaceuticals pte ltd – product pipeline review – 2012
 
Glenmark pharmaceuticals ltd. – product pipeline review – 2012
Glenmark pharmaceuticals ltd. – product pipeline review – 2012Glenmark pharmaceuticals ltd. – product pipeline review – 2012
Glenmark pharmaceuticals ltd. – product pipeline review – 2012
 
Geron corporation – product pipeline review – 2012
Geron corporation – product pipeline review – 2012Geron corporation – product pipeline review – 2012
Geron corporation – product pipeline review – 2012
 
Immuno gen, inc. – product pipeline review – 2012
Immuno gen, inc. – product pipeline review – 2012Immuno gen, inc. – product pipeline review – 2012
Immuno gen, inc. – product pipeline review – 2012
 
7 tm pharma as – product pipeline review – 2012
7 tm pharma as – product pipeline review – 20127 tm pharma as – product pipeline review – 2012
7 tm pharma as – product pipeline review – 2012
 
Emerging power markets in south east asia
Emerging power markets in south east asiaEmerging power markets in south east asia
Emerging power markets in south east asia
 
Cloud computing in pharmaceutical research
Cloud computing in pharmaceutical researchCloud computing in pharmaceutical research
Cloud computing in pharmaceutical research
 

Dernier

MAHA Global and IPR: Do Actions Speak Louder Than Words?
MAHA Global and IPR: Do Actions Speak Louder Than Words?MAHA Global and IPR: Do Actions Speak Louder Than Words?
MAHA Global and IPR: Do Actions Speak Louder Than Words?Olivia Kresic
 
Organizational Structure Running A Successful Business
Organizational Structure Running A Successful BusinessOrganizational Structure Running A Successful Business
Organizational Structure Running A Successful BusinessSeta Wicaksana
 
NewBase 19 April 2024 Energy News issue - 1717 by Khaled Al Awadi.pdf
NewBase  19 April  2024  Energy News issue - 1717 by Khaled Al Awadi.pdfNewBase  19 April  2024  Energy News issue - 1717 by Khaled Al Awadi.pdf
NewBase 19 April 2024 Energy News issue - 1717 by Khaled Al Awadi.pdfKhaled Al Awadi
 
Fordham -How effective decision-making is within the IT department - Analysis...
Fordham -How effective decision-making is within the IT department - Analysis...Fordham -How effective decision-making is within the IT department - Analysis...
Fordham -How effective decision-making is within the IT department - Analysis...Peter Ward
 
Global Scenario On Sustainable and Resilient Coconut Industry by Dr. Jelfina...
Global Scenario On Sustainable  and Resilient Coconut Industry by Dr. Jelfina...Global Scenario On Sustainable  and Resilient Coconut Industry by Dr. Jelfina...
Global Scenario On Sustainable and Resilient Coconut Industry by Dr. Jelfina...ictsugar
 
(Best) ENJOY Call Girls in Faridabad Ex | 8377087607
(Best) ENJOY Call Girls in Faridabad Ex | 8377087607(Best) ENJOY Call Girls in Faridabad Ex | 8377087607
(Best) ENJOY Call Girls in Faridabad Ex | 8377087607dollysharma2066
 
Cyber Security Training in Office Environment
Cyber Security Training in Office EnvironmentCyber Security Training in Office Environment
Cyber Security Training in Office Environmentelijahj01012
 
Digital Transformation in the PLM domain - distrib.pdf
Digital Transformation in the PLM domain - distrib.pdfDigital Transformation in the PLM domain - distrib.pdf
Digital Transformation in the PLM domain - distrib.pdfJos Voskuil
 
Buy gmail accounts.pdf Buy Old Gmail Accounts
Buy gmail accounts.pdf Buy Old Gmail AccountsBuy gmail accounts.pdf Buy Old Gmail Accounts
Buy gmail accounts.pdf Buy Old Gmail AccountsBuy Verified Accounts
 
Innovation Conference 5th March 2024.pdf
Innovation Conference 5th March 2024.pdfInnovation Conference 5th March 2024.pdf
Innovation Conference 5th March 2024.pdfrichard876048
 
Financial-Statement-Analysis-of-Coca-cola-Company.pptx
Financial-Statement-Analysis-of-Coca-cola-Company.pptxFinancial-Statement-Analysis-of-Coca-cola-Company.pptx
Financial-Statement-Analysis-of-Coca-cola-Company.pptxsaniyaimamuddin
 
8447779800, Low rate Call girls in Uttam Nagar Delhi NCR
8447779800, Low rate Call girls in Uttam Nagar Delhi NCR8447779800, Low rate Call girls in Uttam Nagar Delhi NCR
8447779800, Low rate Call girls in Uttam Nagar Delhi NCRashishs7044
 
International Business Environments and Operations 16th Global Edition test b...
International Business Environments and Operations 16th Global Edition test b...International Business Environments and Operations 16th Global Edition test b...
International Business Environments and Operations 16th Global Edition test b...ssuserf63bd7
 
FULL ENJOY Call girls in Paharganj Delhi | 8377087607
FULL ENJOY Call girls in Paharganj Delhi | 8377087607FULL ENJOY Call girls in Paharganj Delhi | 8377087607
FULL ENJOY Call girls in Paharganj Delhi | 8377087607dollysharma2066
 
Darshan Hiranandani [News About Next CEO].pdf
Darshan Hiranandani [News About Next CEO].pdfDarshan Hiranandani [News About Next CEO].pdf
Darshan Hiranandani [News About Next CEO].pdfShashank Mehta
 
8447779800, Low rate Call girls in Shivaji Enclave Delhi NCR
8447779800, Low rate Call girls in Shivaji Enclave Delhi NCR8447779800, Low rate Call girls in Shivaji Enclave Delhi NCR
8447779800, Low rate Call girls in Shivaji Enclave Delhi NCRashishs7044
 
Church Building Grants To Assist With New Construction, Additions, And Restor...
Church Building Grants To Assist With New Construction, Additions, And Restor...Church Building Grants To Assist With New Construction, Additions, And Restor...
Church Building Grants To Assist With New Construction, Additions, And Restor...Americas Got Grants
 
Ten Organizational Design Models to align structure and operations to busines...
Ten Organizational Design Models to align structure and operations to busines...Ten Organizational Design Models to align structure and operations to busines...
Ten Organizational Design Models to align structure and operations to busines...Seta Wicaksana
 

Dernier (20)

MAHA Global and IPR: Do Actions Speak Louder Than Words?
MAHA Global and IPR: Do Actions Speak Louder Than Words?MAHA Global and IPR: Do Actions Speak Louder Than Words?
MAHA Global and IPR: Do Actions Speak Louder Than Words?
 
Organizational Structure Running A Successful Business
Organizational Structure Running A Successful BusinessOrganizational Structure Running A Successful Business
Organizational Structure Running A Successful Business
 
NewBase 19 April 2024 Energy News issue - 1717 by Khaled Al Awadi.pdf
NewBase  19 April  2024  Energy News issue - 1717 by Khaled Al Awadi.pdfNewBase  19 April  2024  Energy News issue - 1717 by Khaled Al Awadi.pdf
NewBase 19 April 2024 Energy News issue - 1717 by Khaled Al Awadi.pdf
 
Enjoy ➥8448380779▻ Call Girls In Sector 18 Noida Escorts Delhi NCR
Enjoy ➥8448380779▻ Call Girls In Sector 18 Noida Escorts Delhi NCREnjoy ➥8448380779▻ Call Girls In Sector 18 Noida Escorts Delhi NCR
Enjoy ➥8448380779▻ Call Girls In Sector 18 Noida Escorts Delhi NCR
 
Fordham -How effective decision-making is within the IT department - Analysis...
Fordham -How effective decision-making is within the IT department - Analysis...Fordham -How effective decision-making is within the IT department - Analysis...
Fordham -How effective decision-making is within the IT department - Analysis...
 
Global Scenario On Sustainable and Resilient Coconut Industry by Dr. Jelfina...
Global Scenario On Sustainable  and Resilient Coconut Industry by Dr. Jelfina...Global Scenario On Sustainable  and Resilient Coconut Industry by Dr. Jelfina...
Global Scenario On Sustainable and Resilient Coconut Industry by Dr. Jelfina...
 
(Best) ENJOY Call Girls in Faridabad Ex | 8377087607
(Best) ENJOY Call Girls in Faridabad Ex | 8377087607(Best) ENJOY Call Girls in Faridabad Ex | 8377087607
(Best) ENJOY Call Girls in Faridabad Ex | 8377087607
 
Cyber Security Training in Office Environment
Cyber Security Training in Office EnvironmentCyber Security Training in Office Environment
Cyber Security Training in Office Environment
 
Digital Transformation in the PLM domain - distrib.pdf
Digital Transformation in the PLM domain - distrib.pdfDigital Transformation in the PLM domain - distrib.pdf
Digital Transformation in the PLM domain - distrib.pdf
 
Buy gmail accounts.pdf Buy Old Gmail Accounts
Buy gmail accounts.pdf Buy Old Gmail AccountsBuy gmail accounts.pdf Buy Old Gmail Accounts
Buy gmail accounts.pdf Buy Old Gmail Accounts
 
Innovation Conference 5th March 2024.pdf
Innovation Conference 5th March 2024.pdfInnovation Conference 5th March 2024.pdf
Innovation Conference 5th March 2024.pdf
 
Financial-Statement-Analysis-of-Coca-cola-Company.pptx
Financial-Statement-Analysis-of-Coca-cola-Company.pptxFinancial-Statement-Analysis-of-Coca-cola-Company.pptx
Financial-Statement-Analysis-of-Coca-cola-Company.pptx
 
8447779800, Low rate Call girls in Uttam Nagar Delhi NCR
8447779800, Low rate Call girls in Uttam Nagar Delhi NCR8447779800, Low rate Call girls in Uttam Nagar Delhi NCR
8447779800, Low rate Call girls in Uttam Nagar Delhi NCR
 
International Business Environments and Operations 16th Global Edition test b...
International Business Environments and Operations 16th Global Edition test b...International Business Environments and Operations 16th Global Edition test b...
International Business Environments and Operations 16th Global Edition test b...
 
Corporate Profile 47Billion Information Technology
Corporate Profile 47Billion Information TechnologyCorporate Profile 47Billion Information Technology
Corporate Profile 47Billion Information Technology
 
FULL ENJOY Call girls in Paharganj Delhi | 8377087607
FULL ENJOY Call girls in Paharganj Delhi | 8377087607FULL ENJOY Call girls in Paharganj Delhi | 8377087607
FULL ENJOY Call girls in Paharganj Delhi | 8377087607
 
Darshan Hiranandani [News About Next CEO].pdf
Darshan Hiranandani [News About Next CEO].pdfDarshan Hiranandani [News About Next CEO].pdf
Darshan Hiranandani [News About Next CEO].pdf
 
8447779800, Low rate Call girls in Shivaji Enclave Delhi NCR
8447779800, Low rate Call girls in Shivaji Enclave Delhi NCR8447779800, Low rate Call girls in Shivaji Enclave Delhi NCR
8447779800, Low rate Call girls in Shivaji Enclave Delhi NCR
 
Church Building Grants To Assist With New Construction, Additions, And Restor...
Church Building Grants To Assist With New Construction, Additions, And Restor...Church Building Grants To Assist With New Construction, Additions, And Restor...
Church Building Grants To Assist With New Construction, Additions, And Restor...
 
Ten Organizational Design Models to align structure and operations to busines...
Ten Organizational Design Models to align structure and operations to busines...Ten Organizational Design Models to align structure and operations to busines...
Ten Organizational Design Models to align structure and operations to busines...
 

B cell non-hodgkin lymphoma – pipeline

  • 1. Aarkstore.com announces, The Latest market research report is available in its vast collection: B-Cell Non-Hodgkin Lymphoma – Pipeline Review, H2 2012 You can also request for sample page of above mention reports on sample@aarkstore.com Summary Global Markets Direct’s, B-Cell Non-Hodgkin Lymphoma - Pipeline Review, Global Markets Direct’s, B-Cell Non-Hodgkin Lymphoma - Pipeline Review, H2 2012, provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic development for B-Cell Non-Hodgkin Lymphoma, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for B- Cell Non-Hodgkin Lymphoma. B-Cell Non-Hodgkin Lymphoma - Pipeline Review, Half Year is built using data and information sourced from Global Markets Direct’s proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct’s team. Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease. Scope - A snapshot of the global therapeutic scenario for B-Cell Non-Hodgkin Lymphoma. - A review of the B-Cell Non-Hodgkin Lymphoma products under development by
  • 2. companies and universities/research institutes based on information derived from company and industry-specific sources. - Coverage of products based on various stages of development ranging from discovery till registration stages. Reasons to buy - Identify and understand important and diverse types of therapeutics under development for B-Cell Non-Hodgkin Lymphoma. - Identify emerging players with potentially strong product portfolio and design effective counter-strategies to gain competitive advantage. Table of contents: List of Tables 6 List of Figures 7 Introduction 8 Global Markets Direct Report Coverage 8 B-Cell Non-Hodgkin Lymphoma Overview 9 Therapeutics Development 10 An Overview of Pipeline Products for B-Cell Non-Hodgkin Lymphoma 10 B-Cell Non-Hodgkin Lymphoma Therapeutics under Development by Companies 12 B-Cell Non-Hodgkin Lymphoma Therapeutics under Investigation by Universities/Institutes 15 Late Stage Products 18 Comparative Analysis 18 Mid Clinical Stage Products 19 Comparative Analysis 19 Early Clinical Stage Products 20 Comparative Analysis 20 Discovery and Pre-Clinical Stage Products 21 Comparative Analysis 21 B-Cell Non-Hodgkin Lymphoma Therapeutics – Products under Development by Companies 22 B-Cell Non-Hodgkin Lymphoma Therapeutics – Products under Investigation by Universities/Institutes 24
  • 3. Companies Involved in B-Cell Non-Hodgkin Lymphoma Therapeutics Development 28 Bristol-Myers Squibb Company 28 Johnson & Johnson 29 Kyowa Hakko Kirin Co., Ltd. 30 Sanofi-Aventis 31 Genentech, Inc. 32 MedImmune LLC 33 Gilead Sciences, Inc. 34 List of Figures List of Tables are also include. For more related Reports Plz follow The link: Pipeline Review, H2 2012 http://www.aarkstore.com/search/viewresults.asp?search=Pipeline Review, H2 2012&PubId=&pagenum=1 Liver Cancer – Pipeline Review, H2 2012 Non-Small Cell Lung Cancer – Pipeline Review, H2 2012 Asthma – Pipeline Review, H2 2012 Multiple Sclerosis – Pipeline Review, H2 2012 Gastrointestinal Tract Cancer – Pipeline Review, H2 2012 Diabetes – Pipeline Review, H2 2012
  • 4. Chronic Lymphocytic Leukemia (CLL) – Pipeline Review, H2 2012 Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) – Pipeline Review, H2 2012 Graft Versus Host Disease (GVHD) – Pipeline Review, H2 2012 Malaria – Pipeline Review, H2 2012 Methicillin-Resistant Staphylococcus Aureus (MRSA) Infections – Pipeline Review, H2 2012 Dermatitis – Pipeline Review, H2 2012 Search More Reports Related to This Category : Pharmaceuticals and Healthcare http://www.aarkstore.com/search/viewresults.asp?search=Pharmaceuticals and Healthcare&PubId=&pagenum=1 For More details Plz do contact : Aarkstore Enterprise Lavanya Phone:08149852585 Email: enquiry@aarkstore.com